THE ROLE OF ARTIFICIAL INTELLIGENCE IN THE EARLY DETECTION OF STROKE

Kamolabonu R. Inomova

Andijan State Medical Institute, Andijan, Uzbekistan

E-mail: inamovak17@gmail.com

ORCID: 0009-0005-4285-4578

Abstract

Stroke is a leading cause of death and long-term disability worldwide. In acute ischemic stroke, timely diagnosis and treatment are critical because the probability of tissue salvage decreases as cerebral ischemia progresses. The principle of “time is brain” therefore underlies modern acute stroke management, particularly when reperfusion therapy is being considered. Recent advances in artificial intelligence (AI), machine learning, and deep learning have created new opportunities to support rapid and standardized interpretation of neuroimaging data.

This review examines the role of AI in the early detection and triage of acute stroke, with particular emphasis on neuroimaging. Current applications include the automated detection of intracranial hemorrhage and ischemic abnormalities on non-contrast computed tomography (NCCT), identification of large-vessel occlusion (LVO) on computed tomography angiography (CTA), automated assessment of the Alberta Stroke Program Early CT Score (ASPECTS), and quantitative analysis of perfusion and magnetic resonance imaging (MRI) data. The potential advantages of AI include rapid image processing, automated alerts, standardized assessment, and support for time-sensitive clinical workflows. However, important limitations remain, including variability in algorithm performance, dataset bias, technical artifacts, false-positive and false-negative results, limited external validation, and uncertainty regarding the effect of AI implementation on patient-centered outcomes.

Current evidence indicates that AI is most appropriately considered a clinical decision-support technology rather than an autonomous diagnostic system. In particular, AI-assisted detection of LVO may improve communication and workflow efficiency and may reduce delays to treatment, although evidence that AI itself improves functional outcomes remains limited. Appropriate external validation, transparency, data protection, and continued physician oversight are therefore essential for safe clinical implementation.

Keywords: stroke; acute ischemic stroke; artificial intelligence; machine learning; deep learning; neuroimaging; computed tomography; CT angiography; CT perfusion; magnetic resonance imaging; large-vessel occlusion; early diagnosis.

Introduction

Stroke is an acute neurological disorder caused by disruption of cerebral blood flow and is broadly classified as ischemic or hemorrhagic. Ischemic stroke occurs when cerebral arterial blood flow is interrupted, most commonly because of thrombotic or embolic occlusion, whereas hemorrhagic stroke results from rupture of a blood vessel and subsequent bleeding within or around the brain.

Acute ischemic stroke is a time-sensitive medical emergency. The extent of irreversible brain injury generally increases with prolonged cerebral ischemia, making rapid recognition, neuroimaging, and selection of appropriate reperfusion therapy fundamental components of acute stroke care [1,2].

Neuroimaging plays a central role in determining the nature and extent of cerebral injury. Non-contrast computed tomography (NCCT) is widely used in the initial assessment because it can rapidly identify intracranial hemorrhage and provide information about early ischemic changes. CT angiography (CTA) is used to evaluate intracranial and extracranial vessels and identify large-vessel occlusion, while CT perfusion (CTP) and MRI can provide additional information regarding tissue viability and the extent of ischemic injury.

Despite major advances in stroke imaging, interpretation remains subject to time constraints, workload, differences in expertise, and the complexity of multimodal imaging datasets. These challenges have stimulated interest in AI-based technologies capable of rapidly analyzing large volumes of imaging data and providing standardized decision-support information [3,4].

Artificial Intelligence in Neurology

Artificial intelligence refers to computational methods designed to perform tasks that typically require human cognitive abilities, including pattern recognition, classification, prediction, and decision support.

Machine learning is a major branch of AI in which algorithms learn statistical patterns from datasets. Deep learning, particularly convolutional neural networks (CNNs), uses multiple layers of artificial neural networks to extract increasingly complex features from data. These approaches are particularly suitable for medical imaging because they can analyze high-dimensional image datasets without requiring every relevant feature to be manually defined.

In acute stroke care, AI has been investigated for several applications, including:

• detection of intracranial hemorrhage;
• detection and quantification of ischemic lesions;
• identification of large-vessel occlusion;
• automated or assisted ASPECTS assessment;
• estimation of infarct-core volume;
• analysis of perfusion imaging;
• segmentation of abnormal brain tissue;
• workflow and stroke-team notification;
• clinical and functional outcome prediction [3–5].

The strongest current clinical application is in imaging-based triage, particularly the rapid detection of LVO and other time-critical abnormalities.

Neuroimaging and Early Stroke Detection

The primary objectives of acute stroke imaging are to distinguish ischemic from hemorrhagic stroke, identify the extent of established brain injury, detect vascular occlusion, and determine whether advanced imaging findings support reperfusion treatment.

Non-contrast CT

NCCT is commonly the first-line imaging examination in patients with suspected acute stroke. Its rapid acquisition and widespread availability make it particularly useful in emergency settings. Intracranial hemorrhage can often be identified rapidly, which is essential because hemorrhage and ischemia require fundamentally different treatment strategies.

AI algorithms can analyze NCCT scans and flag findings suspicious for intracranial hemorrhage or early ischemic change. Such systems may assist radiologists and stroke physicians by prioritizing examinations requiring urgent review [3].

However, AI should not be interpreted as a replacement for expert image assessment. Subtle lesions, motion artifacts, atypical presentations, and technical differences between scanners may affect algorithmic performance.

CT Angiography and Large-Vessel Occlusion

LVO is an important cause of severe acute ischemic stroke and is particularly relevant because eligible patients may benefit from mechanical thrombectomy. Rapid identification of LVO is therefore a major component of modern stroke triage [2,5].

AI-based CTA analysis can assist in detecting occlusion of major intracranial arteries. Earlier systematic reviews demonstrated the feasibility of machine-learning approaches for automated LVO detection, while more recent evidence has continued to support their diagnostic potential [4,5].

AI systems may also generate automated notifications to stroke teams when an LVO is suspected. This can reduce communication delays and facilitate transfer or activation of endovascular treatment pathways.

Nevertheless, diagnostic performance varies according to the vascular territory and algorithm. Detection of distal occlusions, smaller-vessel lesions, and posterior circulation occlusions may remain challenging [6]. Therefore, an AI alert should prompt expert review rather than automatically determine treatment.

Automated Assessment of ASPECTS

The Alberta Stroke Program Early CT Score (ASPECTS) is a standardized scoring system used to estimate the extent of early ischemic change in the middle cerebral artery territory on NCCT.

AI-based systems can assist in the automated identification of regions affected by early ischemic change and provide an estimated ASPECTS. This may reduce interobserver variability and provide standardized quantitative information during time-critical assessment [3,4].

However, automated ASPECTS estimation may be affected by image quality, anatomical variation, pre-existing abnormalities, and segmentation errors. Consequently, AI-derived ASPECTS should be considered supportive information and interpreted in conjunction with the clinical examination and expert neuroimaging assessment.

CT Perfusion and Estimation of the Infarct Core

CT perfusion provides quantitative information about cerebral hemodynamics and may help distinguish established infarcted tissue from hypoperfused tissue that may remain potentially salvageable.

AI can facilitate automated processing of perfusion datasets, calculation of perfusion parameters, and segmentation of regions of abnormal perfusion. These capabilities may be particularly useful when symptom onset is unknown or when patients present beyond conventional early treatment windows and advanced imaging is used for treatment selection [2,3].

However, automated perfusion maps can be affected by motion, poor contrast bolus, incorrect arterial or venous input selection, and other technical factors. Automated estimates should therefore be reviewed for plausibility and interpreted within the clinical context rather than treated as definitive measurements.

MRI and Artificial Intelligence

MRI provides highly sensitive imaging of acute ischemic injury. Diffusion-weighted imaging (DWI), particularly when interpreted together with apparent diffusion coefficient (ADC) maps, is highly useful for identifying acute ischemic lesions.

AI techniques have been investigated for automated lesion detection, segmentation, volume estimation, and quantitative analysis of DWI and perfusion-weighted imaging data [7].

Despite these advantages, MRI may be less suitable than CT as the initial emergency imaging modality in some settings because of longer acquisition times, limited availability, contraindications, and the need for appropriate patient monitoring.

AI-Assisted Clinical Decision-Making

The principal clinical value of AI in acute stroke is its ability to support—not replace—clinical decision-making.

A simplified AI-assisted workflow can be represented as:

Patient presentation → clinical assessment → neuroimaging → AI-assisted analysis → identification of suspected pathology → automated notification → expert review → treatment decision.

This approach is particularly relevant to LVO stroke, where delays in recognition and communication can affect the speed of endovascular treatment.

Evidence from systematic reviews indicates that AI-supported LVO detection can improve workflow efficiency and reduce certain treatment delays. However, recent evidence suggests that improved workflow does not necessarily translate into improved functional outcomes or reduced mortality [8,9]. Therefore, the clinical benefit of AI should be evaluated not only by diagnostic accuracy but also by its effect on meaningful patient outcomes.

Advantages of Artificial Intelligence in Acute Stroke Care

The potential advantages of AI include:

1. Rapid image analysis: large imaging datasets can be processed within seconds or minutes.
2. Automated notification: suspected LVO or intracranial hemorrhage can trigger rapid alerts.
3. Standardization: algorithmic analysis may reduce some forms of interobserver variability.
4. Workflow optimization: automated triage may reduce delays between imaging, communication, and treatment.
5. Decision support: quantitative imaging information may complement clinical assessment.
6. Scalability: AI-based tools may assist healthcare systems with limited access to specialist neuroradiology expertise.

Limitations and Challenges

Despite substantial progress, several limitations restrict the widespread implementation of AI in acute stroke care.

Dataset Bias and Generalizability

AI algorithms depend on the quality and representativeness of the datasets used for development and validation. Differences in patient populations, imaging protocols, scanner manufacturers, disease prevalence, and clinical workflows may affect performance when an algorithm is transferred to a new healthcare environment.

False-Positive and False-Negative Results

No AI system is perfectly accurate. False-positive results can generate unnecessary alerts and increase workload, whereas false-negative results may potentially delay recognition of a treatable lesion.

Explainability

Some deep-learning models provide highly accurate predictions without clearly explaining how a particular conclusion was reached. Limited interpretability may reduce clinician confidence and complicate regulatory and medico-legal considerations.

External Validation

High performance in a development dataset does not necessarily guarantee equivalent performance in routine clinical practice. Independent external validation across multiple institutions and populations is therefore essential.

Clinical Outcomes

One of the most important limitations is the distinction between diagnostic performance and patient benefit. AI may accurately detect LVO or improve workflow metrics without necessarily improving functional independence or survival. Recent meta-analytic evidence supports this distinction: AI-assisted LVO detection has been associated with faster treatment workflows, but improvement in clinical outcomes has not been consistently demonstrated [8,9].

Data Protection and Cybersecurity

The use of AI requires processing potentially sensitive medical information. Patient confidentiality, secure data storage, cybersecurity, and appropriate governance are therefore essential components of responsible implementation.

Future Perspectives

The future of AI in stroke care is likely to involve multimodal systems that integrate imaging, clinical findings, laboratory data, and electronic health-record information.

Such systems may eventually support individualized treatment selection, prediction of functional recovery, identification of patients at high risk of recurrent stroke, and optimization of rehabilitation strategies.

Integration with telemedicine may be particularly valuable in regions where specialist stroke and neuroradiology services are limited. AI could assist remote clinicians in prioritizing patients who require urgent specialist evaluation or transfer.

However, future development should focus not only on improving algorithmic accuracy but also on clinical validation, transparency, interoperability, fairness, cybersecurity, and demonstrable improvements in patient-centered outcomes.

Conclusion

Artificial intelligence has become an important emerging technology in acute stroke imaging and triage. Current applications include automated detection of intracranial hemorrhage, identification of early ischemic abnormalities, LVO detection on CTA, assisted ASPECTS assessment, and quantitative analysis of perfusion and MRI data [3–5].

The greatest current clinical potential of AI lies in accelerating image interpretation, facilitating communication, and optimizing time-sensitive stroke workflows. In particular, AI-assisted LVO detection may reduce delays between imaging and endovascular treatment. Nevertheless, improved workflow or diagnostic accuracy should not automatically be interpreted as proof of improved patient outcomes.

AI should therefore be implemented as a clinical decision-support technology, with final diagnostic and therapeutic decisions remaining under the responsibility of appropriately trained healthcare professionals.

The most promising model for the future of AI-assisted stroke care is not replacement of physicians, but human–AI collaboration. Properly validated and responsibly implemented AI systems may improve the speed, consistency, and efficiency of stroke diagnosis while allowing clinicians to retain responsibility for individualized patient care.

References

1. Campbell B.C.V., De Silva D.A., Macleod M.R., et al. Ischaemic stroke. Nature Reviews Disease Primers. 2019;5:70. doi:10.1038/s41572-019-0118-8.

2. Powers W.J., Rabinstein A.A., Ackerson T., et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211.

3. Soun J.E., Chow D.S., Nagamine M., Takhtawala R.S., Filippi C.G., Yu W., Chang P.D. Artificial Intelligence and Acute Stroke Imaging. American Journal of Neuroradiology. 2021;42(1):2–11. doi:10.3174/ajnr.A6883. (PubMed)

4. Murray N.M., Unberath M., Hager G.D., Hui F.K. Artificial intelligence to diagnose ischemic stroke and identify large-vessel occlusions: a systematic review. Journal of NeuroInterventional Surgery. 2020;12(2):156–164. doi:10.1136/neurintsurg-2019-015135. (PubMed)

5. Shlobin N.A., Baig A.A., Waqas M., et al. Artificial Intelligence for Large-Vessel Occlusion Stroke: A Systematic Review. World Neurosurgery. 2022;159:207–220.e1. doi:10.1016/j.wneu.2021.12.004. (PubMed)

6. Luijten S.P.R., Wolff L., van der Lugt A. The True Potential of Artificial Intelligence for Detection of Large-Vessel Occlusion: The Role of M2 Occlusions. American Journal of Neuroradiology. 2021;42(7):E46. doi:10.3174/ajnr.A7111.

7. Ben Salem D., et al. Applications of artificial intelligence for DWI and PWI data processing in acute ischemic stroke: Current practices and future directions. Clinical Imaging. 2022. doi:10.1016/j.clinimag.2021.09.015. (PubMed)

8. Detection of large vessel occlusion using artificial intelligence tools: a systematic review and meta-analysis. American Journal of Neuroradiology. 2025. (PubMed)

9. Susanti L., Cuandra K.N., Tristan C.D., et al. Diagnostic Test Accuracy of Artificial Intelligence in Large Vessel Occlusion: A Systematic Review and Meta-Analysis. Neurology Research International. 2026;2026:5709868. doi:10.1155/nri/5709868. (PubMed)

10. Yedavalli V.S., Tong E., Martin D., Yeom K.W., Forkert N.D. Artificial intelligence in stroke imaging: Current and future perspectives. Clinical Imaging. 2021;69:246–254. doi:10.1016/j.clinimag.2020.09.005. (PubMed)

11. Nogueira R.G., Jadhav A.P., Haussen D.C., et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. New England Journal of Medicine. 2018;378(1):11–21. doi:10.1056/NEJMoa1706442.

12. Albers G.W., Marks M.P., Kemp S., et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. New England Journal of Medicine. 2018;378(8):708–718. doi:10.1056/NEJMoa1713973.